Sandra E. Peterson is President of Bayer Medical Care and a member of Bayer HealthCare’s Executive Committee. Bayer Medical Care is a portfolio of global medical device companies. Prior to her current role, she was President of Bayer Diabetes Care, where she successfully turned around the global division and achieved twice market growth rates and improved profitability over a sustained 3 year period. Ms. Peterson joined Bayer Healthcare in May of 2005.

Ms. Peterson joined Bayer from Medco Health Solutions, Inc., (formerly Merck-Medco), where she was Group President and as an Executive Management team member, she played a role in the strategic spin-off of Medco Health from Merck & Co., Inc. Prior to the spin-off, she was Senior Vice President of Merck-Medco’s Health Businesses where she launched several new business lines. Areas of responsibility at Medco included general management, business development, strategy, alliance management, product development, branding and marketing. From 1996 – 1999, she was Executive Vice President of Nabisco and held various global executive positions at Whirlpool Corporation from 1993 to 1996.

From 1987 to 1993, Sandra was a management consultant at McKinsey & Company working closely with the top management of major global companies on brand marketing strategies, innovative product development and new business. Initially, Ms. Peterson held finance and policy positions on Wall Street and worked in Germany as a Bosch Fellow serving with the German Federal Ministry of Finance and the Federation of Germany Industries. She holds a B.A. in Government from Cornell University, Ithaca, NY, and a Masters of Public Administration in Applied Economics from Princeton University, Princeton, NJ.

She is a member of the Board of Directors at Dunn & Bradstreet and Chairman of the Board of MEDRAD. In addition, she is Chairman of the Board of Wildlife Trust, a global life sciences non-profit. She is a member of the Committee of 200 and the Women’s Forum. She speaks German and was born in New York, NY, USA.

Olivier Jarry is Chief Operating Officer for Bayer Diabetes Care. Olivier assumed this role in July, 2009.

Olivier joined Bayer from Novartis where his career spanned eight years and during which time he developed an extensive and diverse international and functional background -- including profit and loss (P&L) responsibility in each of the four major regions of the world. He was most recently Head of Novartis' Vaccine division in Western/Eastern Europe, Russia, CIS where he led the division to tremendous growth. Prior to that, Olivier was Head of Novartis' India Rural Business in healthcare, a for-profit initiative to improve access to medicines in rural areas while partnering with local health educators and non-governmental organizations. He also led strategy, business development & licensing for the company's Gerber baby food brand in Asia Pacific and served as General Manager for their Latin America Consumer Health business. Prior to Novartis, Olivier worked for Danone in France and in the US where he developed their beverage and imported good businesses.

Olivier began his career with Accenture working with various companies throughout the globe to define their strategy and improve their operations. He holds an undergraduate degree in Aerospace Engineering and Business Administration from Ecole Centrale de Paris and an MBA from the TRIUM Global Executive MBA program.

Jon Achenbaum joined Bayer HealthCare, Diabetes Care as Global Chief Marketing Officer in February 2006. Late in 2006 he was given the additional responsibility to lead the Latin American Commercial Operations for the Diabetes Care division. In his role as Global Chief Marketing Officer, Jon is responsible for leading product management, brand strategy, marketing communications, eMarketing, competitive intelligence, customer and market insight, packaging and design, and medical marketing.

Jon's background includes nine years with Unilever in several roles, including Senior Vice President of Global Skin Innovation, General Manager of the North American Hair and Oral Care businesses as well as President of Lever Ponds in Canada. Prior to Unilever, Jon worked for Helene Curtis in Brand Management, Business Development and Marketing Resources. He began his career at Quaker Oats and Pillsbury.

Jon holds a BA from Skidmore College and studied at New York University's Graduate School of Business.

Nancy Katz joined Bayer Healthcare, Diabetes Care in 2005 as Head of North America Sales and Marketing. In this role, she is responsible for planning, organizing and leading the development, implementation and evaluation of all sales, marketing and distribution for new and existing Diabetes Care Division products within North America (U.S., Canada, and Puerto Rico) in order to achieve sales, profit, and supply chain objectives.

Nancy has a twenty-plus year track record of achievement in commercialization and franchise revitalization. Before owning her own consulting firm, Nancy held many executive positions including President and CEO of Calypte Biomedical in California, which manufactures a urine HIV diagnostic kit; President of Zila Pharmaceuticals in Arizona, a manufacturer of oral care OTC and gingivitis prescription products; Vice President of Sales and Marketing for Johnson & Johnson's LifeScan Division; Senior Director and General Manager for Schering-Plough Healthcare Products; and Brand and Product Manager for American Home Products.

She holds a B.A. in Business Administration from the University of South Florida and was a member of the board with Neoprobe Corporation (NEOP.OB), and Planned Parenthood Golden Gate, California.

Gaetan de Kerros was appointed Head of Asia Region on January 1, 2007. This Region consists of 5 countries (sub regions): Japan, China, India, Korea and Central & South East Asia. In this role, he is responsible for leading the regional organization, managing the sales, marketing and operations in order to achieve financial objectives.

He joins Bayer Diabetes Care from the Bayer HealthCare Asia Pacific Management Team where he was the Regional Business Manager for Asia. He played a key role in shaping up the entry strategies for Bayer Diabetes Care in both China and India, as well as designing and implementing brand new organizations there. Prior to the Asia roles, he was Regional Marketing Manager, out of Tarrytown, USA, worldwide headquarters of Bayer HealthCare Diagnostics Division. Before, he had various positions across sales and marketing, in both France, and the UK.

Gaetan holds a B.A. in Business Management from Ecole Superieure de Gestion, Paris, and Economics Science Degree from the University of Paris VI. Prior to starting his career, he served for one year in the French Navy.

Wayne A. Krampel joined Bayer HealthCare Product Supply organization and Diabetes Care in June 2008 as Vice President for Global Product Supply for Diabetes Care. Wayne brings an impressive record of accomplishment in supply chain management, having held leadership roles at Johnson & Johnson, Federal Express and Medtronic. Most recently, Wayne held the position of Vice President for Supply Chain Management at Johnson and Johnson's Cordis Corp, a manufacturer of vascular technology with $4 billion in annual global sales.

At FedEx, Wayne was responsible for the entire supply chain services product portfolio, as well as the outsourced services strategy for the company. Wayne has extensive experience in the development and execution of comprehensive supply chain strategies designed to influence customer service levels, market demand, and market share.

Wayne began his career in professional services consulting with positions at Ernst and Young, Accenture and Mercer where he specialized in supply chain management. He is on the Board of the University of Michigan's Supply Chain Master's program and a member of the Council of Supply Chain Management Professionals. Wayne holds a degree in business from Cornell University.

Andrea MacGillivray is Vice President, Quality Assurance/Regulatory Affairs for Bayer Diabetes Care. Andrea assumed this role in April, 2008.

Andrea joined Bayer from Roche Pharmaceuticals where she was Area Head for Infomatics Quality. Prior to Roche, Andrea held the role of Vice President of Drug and Device Quality Assurance for J&J, overseeing more than 300 quality assurance professionals. Andrea's career at J&J spanned 13 years during which time she managed quality systems for multiple business areas including Lab Operations for Ortho-Clinical Diagnostics, based in San German, Puerto Rico. She brings extensive experience in process re-engineering, strategic decision-making, and technical compliance management.

She began her career as an engineer in 1985 after graduating from Stanford University. She later earned her MBA at the University of Navarra, IESE, Barcelona, Spain.

Laura Mezey is Vice President and Assistant General Counsel for Bayer HealthCare LLC, and has been a member of Diabetes Care management team since June 2004. Prior her current position, she was Assistant General Counsel for Bayer HealthCare LLC. Laura began her career at Bayer as Senior Counsel at Bayer HealthCare's Diagnostics Division, supporting the Self Testing Segment and Self Test business of the U.S. branch.

Prior to joining Bayer, Laura was a Legal Director at Schering-Plough Corporation, where she supported both the consumer care and prescription drug businesses.

Her professional career began in 1988, when she joined the Wall Street law firm of Cahill Gordon & Reindel, specializing in litigation.

Laura received a B.S. in Foreign Service from Georgetown University and a J.D. from New York University School of Law.

Roberto Parotelli was appointed Head of the International Region for Diabetes Care on June 1, 2004. This Region comprises the European countries and Japan, and, in this role, Mr. Parotelli is responsible for Sales, Marketing and Customer Service for the business.

Prior to this appointment, Mr. Parotelli was BGR for the Diagnostics Division, based in Fernwald, Germany, and before that, he served as BGR for Italy, based in Milan, from 1997 to 2002.

Mr. Parotelli began his career with Bayer in 1975 as Production Manager for the Allergy Unit in Milan, and, in 1985, he became Business Unit Manager for Allergy. In 1990, he joined the Pharmaceutical International Marketing Group in Leverkusen as Product Manager for Nisoldipin. In 1992, he became Sales Manager for the Pharmaceutical Division in Milan, Italy, and the following year, he became Sales and Marketing Manager for Bayer Pharma's Cardiovascular and Anti-Infectives Division.

Mr. Parotelli received a Diploma and Doctorate in Physics from the University of Milan.

Michael Schwartz was appointed Vice President, Global Business Planning and Administration on April 1, 2009. In this role, Michael has global responsibility for finance for Diabetes Care.

Michael has nearly 20 years experience with Bayer. Prior to joining Diabetes Care, he was Head of Finance & Controlling with Bayer HealthCare (BHC) Central Administration & Organization in Leverkusen, Germany, where had responsibility for Controlling, Risk Management, Commercial Evaluation, and Transfer Pricing. He also had functional responsibility for BHC platforms in Asia, Europe and Latin America. Since joining Bayer in 1990, Michael has focused on Controlling and Accounting but has also worked in Marketing, New Business and Sales at BHC mainly within the Consumer Care division. He also spent some years within the Bayer AG Holding and his global experience includes seven years in assignments in China and Indonesia.

After completion of a commercial apprenticeship at Bayer, Michael attended Cologne University and graduated with a degree in Business Administration.

Lynne de Sherbinin is Vice President, Human Resources at Bayer HealthCare's Diabetes Care Division with responsibility for managing the Global Human Resources activities for 2,000 employees worldwide.

Lynne began her career in Human Resources at North American Philips Corporation (Philips Electronics) in 1979. She joined Bayer in 1988 as a Human Resources Representative at Miles Labs and was promoted to Manager, Human Resources for the Diagnostics Division in 1992. Lynne left Bayer in 1996 and became Director, Human Resources, for Moore Business Forms (Lake Forest, IL), with responsibility for 1000 sales and marketing employees on the east coast. She returned to Bayer in 1998, when she relocated to Bayer AG Headquarters in Leverkusen, Germany, working in the Pharma organization and subsequently in the Diagnostics Division's Dublin, Ireland, facility. She moved back to the U.S. in spring of 2003, and became head of HR for Diabetes Care in 2004.

Lynne has a B.A. in Education from The Defiance College (Defiance, OH). She is a local and national member of the Society of Human Resource Management (SHRM).

In his role as Vice President, Chief Medical Officer for Bayer Healthcare, Diabetes Care, David Simmons is responsible for translating the medical context in which the company's products are used, supporting medical education activities required for market development, providing clinical perspective on business development opportunities, and leading clinical trial development that supports regulatory approval and commercial success of the brand.

David has more than thirty years of experience in research, patient care, and education in the field of diabetes and related disorders. Prior to joining Bayer, he spent eight years with Pfizer as Medical Director and Senior Director. He was Team Leader for Exubera® and was responsible for the U.S. product launch, including providing medical marketing support to the U.S. commercial team, and maintaining alignment with the Worldwide and R & D diabetes teams. Prior to his industry career, David spent sixteen years on the faculty in the Division of Endocrinology, Diabetes, and Metabolism of the Department of Medicine, and as Staff Physician at the Hospital of the University of Pennsylvania.

David has an M.D. from the University of Pennsylvania, trained in internal medicine at Baylor College of Medicine Affiliated Hospitals in Houston, and a fellowship in diabetes care and research at the George S. Cox Institute in Pennsylvania.

Rick Stadterman joined Bayer HealthCare, Diabetes Care in 2005 as Head of Global R&D. In this role, he is responsible for developing and commercializing the right mix of products in the Diabetes Care portfolio and finding the best way to bring them to market as quickly as possible — leveraging the company's core competencies in ways to enhance marketplace success.

Prior to joining Bayer, Rick was Senior Vice President, Research & Development, Callaway Golf Company, Inc., Carlsbad, CA, responsible for managing a $30 million product development budget to generate new products for the company. While at Callaway, he initiated training and incorporation of a Six Sigma culture within the R&D team. For three years, Rick was Director, Global Engineering, Schick Wilkinson Sword Division, Pfizer Company, Milford, CT, responsible for the worldwide engineering leadership in the company's shaving products business. Prior to Schick, Rick held positions at several divisions of GE. He began his career as a Research Engineer at Dow Chemical Company, Midland, MI in 1975.

Rick is a Chemical Engineering graduate of the Massachusetts Institute of Technology (MIT) in Cambridge, MA and an MBA graduate from Pepperdine University, Malibu, CA.